Semaglutide for diabetes (Ozempic) starts at 0.25 mg weekly, whilst semaglutide for weight management (Wegovy) begins at the same dose before titrating to 2.4 mg
has served as a consultant for AbbVie, Astellas, AstraZeneca, Boehringer Ingelheim, Fresenius, Gilead, Janssen, Merck, Mundipharma, Mitsubishi Tanabe, and Retrophin and has received grant support from AbbVie, AstraZeneca, Boehringer Ingelheim, and Janssen
Interactions with Other Medications : Semaglutide may interact with other medications, particularly certain oral drugs
the extent to which people who are using these drugs for weight loss fall within the indications of the NICE guidelines)
Stay hydrated drinking plenty of water helps your body process the nutrients
Microdose semaglutide uses a lower-dose GLP-1 strategy